advertisement
Sun C 57
Showing records 1 to 25 | Display all abstracts from Sun C119456 Incidence of Uveitis Following Initiation of Prostaglandin Analogs Versus Other Glaucoma Medications: A Study from the SOURCE Repository
Chauhan MZ
Ophthalmology. Glaucoma 2024; 0:
123323 Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response
Fang R
bioRxiv : the preprint server for biology 2024; 0:
119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Yuan H
Biomarkers in medicine 2024; 18: 545-553
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Liu K
GLIA 2024; 72: 1555-1571
124669 Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
Bressler NM
JAMA ophthalmology 2024; 142: 772-776
119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Li A
Biomarkers in medicine 2024; 18: 545-553
119456 Incidence of Uveitis Following Initiation of Prostaglandin Analogs Versus Other Glaucoma Medications: A Study from the SOURCE Repository
Elhusseiny AM
Ophthalmology. Glaucoma 2024; 0:
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Yang Y
GLIA 2024; 72: 1555-1571
123323 Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response
Zhang P
bioRxiv : the preprint server for biology 2024; 0:
124669 Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
Freund KB
JAMA ophthalmology 2024; 142: 772-776
119456 Incidence of Uveitis Following Initiation of Prostaglandin Analogs Versus Other Glaucoma Medications: A Study from the SOURCE Repository
Marwah S
Ophthalmology. Glaucoma 2024; 0:
124669 Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
Bakri SJ
JAMA ophthalmology 2024; 142: 772-776
119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Chen L
Biomarkers in medicine 2024; 18: 545-553
123323 Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response
Kim D
bioRxiv : the preprint server for biology 2024; 0:
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Wu Z
GLIA 2024; 72: 1555-1571
119456 Incidence of Uveitis Following Initiation of Prostaglandin Analogs Versus Other Glaucoma Medications: A Study from the SOURCE Repository
Marwah S; Sallam AB
Ophthalmology. Glaucoma 2024; 0:
119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Wang Z
Biomarkers in medicine 2024; 18: 545-553
123323 Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response
Kweon J
bioRxiv : the preprint server for biology 2024; 0:
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Sun C
GLIA 2024; 72: 1555-1571
124669 Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
Kim JE
JAMA ophthalmology 2024; 142: 772-776
123323 Robotic Visible-Light Optical Coherence Tomography Visualizes Segmental Schlemm's Canal Anatomy and Segmental Pilocarpine Response
Sun C
bioRxiv : the preprint server for biology 2024; 0:
124669 Intraocular Pressure Outcomes After Lampalizumab Injections in Patients With Geographic Atrophy
Ferrara D
JAMA ophthalmology 2024; 142: 772-776
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Su Y
GLIA 2024; 72: 1555-1571
119379 α-1 antitrypsin is promising for the identification of glaucoma severity and is associated with glaucomatous neural damage
Zhu X
Biomarkers in medicine 2024; 18: 545-553
119137 Remyelination-oriented clemastine treatment attenuates neuropathies of optic nerve and retina in glaucoma
Huang N
GLIA 2024; 72: 1555-1571
